News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Job Trends
Novalar Pharmaceuticals, Inc. Plans Shutdown Following Sale of OraVerse to Septodont, to Cut 12 Jobs
March 23, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Xconomy -- It turns out that Novalar Pharmaceuticals’ decision to sell OraVerse, its dental anesthesia reversal agent, was only half the story.
Twitter
LinkedIn
Facebook
Email
Print
Job creations
MORE ON THIS TOPIC
Layoff Tracker
Recursion Cuts 20% of Workforce
June 11, 2025
·
222 min read
·
BioSpace Editorial Staff
Job Trends
Early-Career Professionals Face Steep Climb in Tight Market
June 11, 2025
·
5 min read
·
Angela Gabriel
Special edition
Deep Dive: Top Paid Pharma Execs—and Those Who Would Get the Most to Leave
June 10, 2025
·
2 min read
·
Annalee Armstrong
Career Advice
The Top 12 Companies Hiring in Biopharma Now
June 5, 2025
·
1 min read
·
Angela Gabriel
